MTX Discontinuation After Achieving Disease Control With TCZ+MTX in RA - Rheumatology Advisor

MTX Discontinuation After Achieving Disease Control With TCZ+MTX in RA  Rheumatology Advisor

In a subset of patients who achieved low disease activity with tocilizumab plus methotrexate (MTX), minimal further MRI-assessed changes were observed in ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases